Keynote Speakers
Joseph Wang Chair of Nanoengineering, SAIC Endowed Professor, Director at Center of Wearable Sensors, University of California-San Diego |
Charles Henry Professor and Chair, Colorado State University |
Paul Yager Professor, Department of Bioengineering, University of Washington |
Bernhard Weigl Director, Center for In-Vitro Diagnostics, Intellectual Ventures/Global Good-Bill Gates Venture Fund |
Ellen Jo Baron Executive Director, Medical Affairs, Cepheid |
Arben Merkoçi ICREA Professor and Director of the Nanobioelectronics & Biosensors Group, Institut Català de Nanociencia i Nanotecnologia (ICN2), Barcelona Institute of Science and Technology (BIST) |
|
Michael Heller Professor, Dept Bioengineering, University of California-San Diego |
Gene Dantsker Director, Business Development and Licensing, Qualcomm LIFE, Inc. |
Hsueh-Chia Chang Bayer Professor of Chemical and Biomolecular Engineering, University of Notre Dame, Interim Chief Technology Officer, Aopia Biosciences |
John Brennan Professor and Director, Biointerfaces Institute, McMaster University |
Alexis Sauer-Budge Biotechnology Managing Scientist, Exponent, Inc., Adjunct Research Assistant Professor, Biomedical Engineering Dept, Boston University |
Steve Soper Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas |
Shoji Takeuchi Professor, Center For International Research on Integrative Biomedical Systems (CIBiS), Institute of Industrial Science, The University of Tokyo |
Gavi Begtrup Chief Executive Officer, Eccrine Systems, Inc. |
Chamindie Punyadeera Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology |
Martyn Boutelle Professor of Biomedical Sensors Engineering, Imperial College London |
Dino Di Carlo Armond and Elena Hairapetian Chair in Engineering and Medicine, Professor and Vice Chair of Bioengineering, University of California-Los Angeles |
David Wong Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles |
Kamlesh Patel R&D Advanced System Engineering and Deployment Manager, Sandia National Laboratories |
John T McDevitt Professor, Division of Biomaterials, New York University College of Dentistry Bioengineering Institute |
OverviewWelcome to the Select Biosciences 5th Annual Point-of-Care Diagnostics, Global Health and Emerging Viral Diseases World Congress 2017.This annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health
fields and bring in the Emerging Viral Diseases field providing the most up-to-date presentations from leaders in
these fields and offer networking and engagement opportunities with
delegates from around the world. This conference will provide an
overview of the point-of-care (POC) testing landscape, from novel
technologies to regulatory approval. Experts in these fields will share
their views on point-of-care in the clinical setting. The aim of this
meeting is to bring together life science researchers that work at the
interface between biology and chemistry and technology development to
discuss problems, highlight solutions and facilitating collaborations.
Also, we frame the role of POC testing in the expanding Global Health
field and highlight opportunities existing in many parts of the world. This
conference covers POC Detection, POC Diagnostics and POC-based
Treatment Options as part of the Comprehensive Coverage of this
Expanding Field. The POC testing field is expanding focused not only on
infectious disease diagnostics (which represents approximately 80% of
the marketplace) but also with cancer and cardiovascular disease focus.
We address each of these segments in this conference. Registered conference delegates have access to the co-located parallel conferences: - Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications 2017
- Lab-on-a-Chip and Microfluidics: Techologies and Commercialization 2017
- Point-of-Care Diagnostics Global Health and Emerging Viral Diseases World Congress2017
- Biosecurity and Biosensors Summit 2017
The Exhibit Hall is Co-Located with the Conference Tracks and is open October 2-4, 2017.
Agenda Topics- Global Health and Emerging Viral Diseases such as Ebola and Zika
- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Emerging Technologies and Emerging Companies Showcase
- Low-Cost POC Devices for Deployment Worldwide
- POC Diagnostics in Resource-Limited Settings
- POC Diagnostics for Global Health: A Worldwide Perspective
- POC Diagnostics in Cancer and Oncology Testing
- POC Diagnostics in Cardiovascular Disease Testing
- POC Diagnostics in Infectious Disease Testing
- Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing for Global Health
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateAmy Adelberger, Founder and CEO, Global Impact Advisors Holger Becker, Chief Scientific Officer, Microfluidic ChipShop GmbH Jane Brock, Chief of Breast Pathology, Brigham and Women’s Hospital, Harvard Medical School Debra English, Manager Biochemistry Applications, GVS North America Joany Jackman, Senior Scientist, Technical Lead, Technology Development Core, Johns Hopkins Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases, The Johns Hopkins University Applied Physics Laboratory Benson U Wang Lei, Researcher, University of Queensland Changchun Liu, Research Associate Professor, University of Pennsylvania Brendan O' Farrell, President, DCN Diagnostics Barbara Smith, Assistant Professor, School of Biological and Health Systems Engineering, Arizona State University John Zeis, CEO, Toolbox Medical Innovations
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|